确定虚拟触觉量化无创评估肝纤维化可靠性的标准
该前瞻性研究纳入1094例慢性肝病患者,以肝活检为参考标准,评估虚拟触觉量化(VTQ)诊断晚期肝纤维化和肝硬化的准确性,并依据四分位距/中位数(IQR/M)与VTQ值定义不可靠、可靠和非常可靠三级标准。VTQ诊断晚期肝纤维化AUROC为0.773±0.014,肝硬化AUROC为0.839±0.014;可靠性分级与正确分类率显著相关。
要点
- VTQ诊断晚期肝纤维化(F≥3或F≥2)AUROC为0.773±0.014,正确分类72.0%。
- VTQ诊断肝硬化AUROC为0.839±0.014,正确分类78.4%。
- 可靠性标准:不可靠(IQR/M≥0.35且VTQ≥1.37 m/s)、可靠(IQR/M≥0.35且VTQ<1.37 m/s或IQR/M 0.15-0.34)、非常可靠(IQR/M<0.15)。
核心结论
- VTQ检查可分为不可靠、可靠和非常可靠3类;IQR/M≥0.35且VTQ≥1.37 m/s的检查诊断准确性很低。
研究设计与样本
- 前瞻性研究,纳入1094例慢性肝病患者,2009年11月至2016年10月在昂热大学医院、2010年4月至2015年5月在波尔多大学医院入组。
- 所有患者接受肝活检分析(参考标准),VTQ检查由经验丰富的操作者在同一天或前后不超过3个月内完成。
- 晚期肝纤维化定义为NASH临床研究网络评分系统F≥3或Metavir评分系统F≥2。
主要发现
- VTQ诊断晚期肝纤维化AUROC为0.773±0.014,采用诊断界值1.37 m/s时正确分类72.0%的患者。
- VTQ诊断肝硬化AUROC为0.839±0.014,采用界值1.87 m/s时正确分类78.4%的患者。
- 在VTQ结果为中高值的患者中,VTQ可靠性随IQR/M比值增加而降低。
- 晚期肝纤维化:不可靠组正确分类57.8%,可靠组73.7%,非常可靠组80.9%(P < .001);肝硬化:分别为50.0%、83.4%、92.6%(P < .001)。
- VTQ检查中21.4%为不可靠,55.0%为可靠,23.6%为非常可靠;皮肤-肝包膜距离≥30 mm的患者中52.7%出现不可靠VTQ检查,该距离与不可靠检查独立相关。
关键数值与推荐
- 不可靠:IQR/M ≥0.35且VTQ结果≥1.37 m/s;可靠:IQR/M ≥0.35且VTQ结果<1.37 m/s或IQR/M 0.15-0.34;非常可靠:IQR/M <0.15。
- 晚期肝纤维化诊断界值1.37 m/s,肝硬化诊断界值1.87 m/s。
临床怎么用
- 作者认为,VTQ肝纤维化评估的可靠性标准将帮助医生准确评估慢性肝病严重程度并监测其进展。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Virtual Touch Quantification (VTQ) evaluates liver fibrosis in patients with chronic liver diseases by measuring shear wave speed in the liver. We aimed to determine the reliability criteria of VTQ examination. METHODS: We performed a prospective study of 1094 patients with chronic liver disease from November 2009 through October 2016 at Angers University Hospital, and between April 2010 and May 2015 at Bordeaux University Hospital, in France. All patients underwent liver biopsy analysis (reference standard), and VTQ examination was made by experienced operators on the same day, or no more than 3 months before or afterward. Advanced liver fibrosis was defined as fibrosis stage F ≥ 3 according to the scoring system of the Nonalcoholic Steatohepatitis Clinical Research Network, or fibrosis stage F ≥ 2 according to the Metavir scoring system. The diagnostic accuracy of VTQ in detection of advanced fibrosis or cirrhosis was assessed using the area under the receiver operating characteristic (AUROC) and the rate of correctly classified patients. Reliability criteria were defined from the intrinsic characteristics of VTQ examination, which were shown to influence the diagnostic accuracy. RESULTS: VTQ identified patients with advanced fibrosis with an AUROC of 0.773 ± 0.014 and correctly classified 72.0% of patients using a diagnostic cut-off value of 1.37 m/s. VTQ identified patients with cirrhosis with an AUROC value of 0.839 ± 0.014 and correctly classified 78.4% of patients using a cut-off value of 1.87 m/s. The reliability of VTQ decreased with an increasing ratio of interquartile range/median (IQR/M) in patients with intermediate-high VTQ results. We defined 3 reliability categories for VTQ: unreliable (IQR/M ≥0.35 with VTQ result ≥1.37 m/s), reliable (IQR/M ≥0.35 with VTQ result <1.37 m/s or IQR/M 0.15-0.34), and very reliable (IQR/M <0.15). For advanced fibrosis, VTQ correctly classified 57.8% of patients in the unreliable group, 73.7% of patients in the reliable group, and 80.9% of patients in the very reliable group (P < .001); for cirrhosis, these values were 50.0%, 83.4%, and 92.6%, respectively (P < .001). Of the VTQ examinations made, 21.4% were unreliable, 55.0% were reliable, and 23.6% were very reliable. The skin-liver capsule distance was independently associated with an unreliable VTQ examination, which occurred in 52.7% of patients with a distance of 30 mm or more. CONCLUSIONS: In a study to determine the reliability of VTQ findings, compared with results from biopsy analysis, we assigned VTQ examinations to 3 categories (unreliable, reliable, and very reliable). VTQ examinations with IQR/M ≥0.35 and ≥1.37 m/s had very low diagnostic accuracy. Our reliability criteria for liver fibrosis assessment with VTQ will help physicians to accurately evaluate the severity of chronic liver diseases and monitor their progression.
引用
- Boursier J, Cassinotto C, Hunault G, et al. Criteria to Determine Reliability of Noninvasive Assessment of Liver Fibrosis With Virtual Touch Quantification. Clin Gastroenterol Hepatol. 2018. PMID: 29753082. doi:10.1016/j.cgh.2018.04.062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。